APO Research
Talk to an analyst

APO RESEARCH · REPORT

Celiac Drugs

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Celiac Drugs Market Outlook and Growth Opportunities 2026

22 December 2025204 pages

Choose your research edition.

Industry ResearchCeliac Drugs Industry Research Report 2026146 pages · $2,950 USDIndustry Growth & TrendsGlobal Celiac Drugs Industry Growth and Trends Forecast to 2032127 pages · $3,450 USDMarket StructureGlobal Celiac Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Celiac Drugs Market Outlook and Growth Opportunities 2026204 pages · $4,250 USDMarket Analysis & ForecastGlobal Celiac Drugs Market Analysis and Forecast 2026-2032208 pages · $4,950 USD

Market perspective

The global Celiac Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Celiac Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Celiac Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Celiac Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Celiac Drugs market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Celiac Drugs market include Johnson & Johnson, Novartis, Merck, Biogen, Bayer, Amgen, LFB Group, Kedrion Biopharma and Innovate Biopharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Celiac Drugs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Celiac Drugs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Celiac Drugs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Celiac Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.

Celiac Drugs Segment by Company

Johnson & Johnson

Novartis

Merck

Biogen

Bayer

Amgen

LFB Group

Kedrion Biopharma

Innovate Biopharmaceuticals

ImmusanT

Immunomedics

ImmunogenX

F Hoffmann-La Roche

Celimmune

Celgene

Bristol-Myers Squibb

Biotest

BioLineRx

Anthera Pharmaceuticals

ADMA Biologics

Celiac Drugs Segment by Type

First Line Of Treatment

Second Line Of Treatment

Celiac Drugs Segment by Application

Women

Men

Children

Celiac Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Celiac Drugs status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Celiac Drugs market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Celiac Drugs significant trends, drivers, influence factors in global and regions.

6. To analyze Celiac Drugs competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Celiac Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Celiac Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Celiac Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Celiac Drugs market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Celiac Drugs industry.

Chapter 3: Detailed analysis of Celiac Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Celiac Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Celiac Drugs in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Celiac Drugs Industry Trends Table 2. Celiac Drugs Industry Drivers Table 3. Celiac Drugs Industry Opportunities and Challenges Table 4. Celiac Drugs Industry Restraints Table 5. Global Celiac Drugs Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Celiac Drugs Revenue Share by Company (2021-2026) Table 7. Global Celiac Drugs Sales Volume by Company (k units) & (2021-2026) Table 8. Global Celiac Drugs Sales Volume Share by Company (2021-2026) Table 9. Global Celiac Drugs Average Price (US$/unit) of Company (2021-2026) Table 10. Global Celiac Drugs Company Ranking, (2024-2026) & (USD Million) Table 11. Global Celiac Drugs Key Company Manufacturing Base & Headquarters Table 12. Global Celiac Drugs Company, Product Type & Application Table 13. Global Celiac Drugs Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Celiac Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of First Line Of Treatment Table 18. Significant Companies of Second Line Of Treatment Table 19. Global Celiac Drugs Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 20. Global Celiac Drugs Sales Volume by Type (2021-2026) & (k units) Table 21. Global Celiac Drugs Sales Volume by Type (2027-2032) & (k units) Table 22. Global Celiac Drugs Sales Volume Share by Type (2021-2026) Table 23. Global Celiac Drugs Sales Volume Share by Type (2027-2032) Table 24. Global Celiac Drugs Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Celiac Drugs Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Celiac Drugs Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Celiac Drugs Sales Value Share by Type (2021-2026) Table 28. Global Celiac Drugs Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Women Table 30. Significant Companies of Men Table 31. Significant Companies of Children Table 32. Global Celiac Drugs Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 33. Global Celiac Drugs Sales Volume by Application (2021-2026) & (k units) Table 34. Global Celiac Drugs Sales Volume by Application (2027-2032) & (k units) Table 35. Global Celiac Drugs Sales Volume Share by Application (2021-2026) Table 36. Global Celiac Drugs Sales Volume Share by Application (2027-2032) Table 37. Global Celiac Drugs Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Celiac Drugs Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Celiac Drugs Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Celiac Drugs Sales Value Share by Application (2021-2026) Table 41. Global Celiac Drugs Sales Value Share by Application (2027-2032) Table 42. Global Celiac Drugs Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 43. Global Celiac Drugs Sales by Region (2021-2026) & (k units) Table 44. Global Celiac Drugs Sales Market Share by Region (2021-2026) Table 45. Global Celiac Drugs Sales by Region (2027-2032) & (k units) Table 46. Global Celiac Drugs Sales Market Share by Region (2027-2032) Table 47. Global Celiac Drugs Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Celiac Drugs Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Celiac Drugs Sales Value Share by Region (2021-2026) Table 50. Global Celiac Drugs Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Celiac Drugs Sales Value Share by Region (2027-2032) Table 52. Global Celiac Drugs Market Average Price (US$/unit) by Region (2021-2026) Table 53. Global Celiac Drugs Market Average Price (US$/unit) by Region (2027-2032) Table 54. Global Celiac Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 55. Global Celiac Drugs Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Celiac Drugs Sales by Country (2021-2026) & (k units) Table 57. Global Celiac Drugs Sales Market Share by Country (2021-2026) Table 58. Global Celiac Drugs Sales by Country (2027-2032) & (k units) Table 59. Global Celiac Drugs Sales Market Share by Country (2027-2032) Table 60. Global Celiac Drugs Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Celiac Drugs Sales Value Market Share by Country (2021-2026) Table 62. Global Celiac Drugs Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Celiac Drugs Sales Value Market Share by Country (2027-2032) Table 64. Johnson & Johnson Company Information Table 65. Johnson & Johnson Business Overview Table 66. Johnson & Johnson Celiac Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 67. Johnson & Johnson Celiac Drugs Product Portfolio Table 68. Johnson & Johnson Recent Development Table 69. Novartis Company Information Table 70. Novartis Business Overview Table 71. Novartis Celiac Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 72. Novartis Celiac Drugs Product Portfolio Table 73. Novartis Recent Development Table 74. Merck Company Information Table 75. Merck Business Overview Table 76. Merck Celiac Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 77. Merck Celiac Drugs Product Portfolio Table 78. Merck Recent Development Table 79. Biogen Company Information Table 80. Biogen Business Overview Table 81. Biogen Celiac Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 82. Biogen Celiac Drugs Product Portfolio Table 83. Biogen Recent Development Table 84. Bayer Company Information Table 85. Bayer Business Overview Table 86. Bayer Celiac Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 87. Bayer Celiac Drugs Product Portfolio Table 88. Bayer Recent Development Table 89. Amgen Company Information Table 90. Amgen Business Overview Table 91. Amgen Celiac Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 92. Amgen Celiac Drugs Product Portfolio Table 93. Amgen Recent Development Table 94. LFB Group Company Information Table 95. LFB Group Business Overview Table 96. LFB Group Celiac Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 97. LFB Group Celiac Drugs Product Portfolio Table 98. LFB Group Recent Development Table 99. Kedrion Biopharma Company Information Table 100. Kedrion Biopharma Business Overview Table 101. Kedrion Biopharma Celiac Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 102. Kedrion Biopharma Celiac Drugs Product Portfolio Table 103. Kedrion Biopharma Recent Development Table 104. Innovate Biopharmaceuticals Company Information Table 105. Innovate Biopharmaceuticals Business Overview Table 106. Innovate Biopharmaceuticals Celiac Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 107. Innovate Biopharmaceuticals Celiac Drugs Product Portfolio Table 108. Innovate Biopharmaceuticals Recent Development Table 109. ImmusanT Company Information Table 110. ImmusanT Business Overview Table 111. ImmusanT Celiac Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 112. ImmusanT Celiac Drugs Product Portfolio Table 113. ImmusanT Recent Development Table 114. Immunomedics Company Information Table 115. Immunomedics Business Overview Table 116. Immunomedics Celiac Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 117. Immunomedics Celiac Drugs Product Portfolio Table 118. Immunomedics Recent Development Table 119. ImmunogenX Company Information Table 120. ImmunogenX Business Overview Table 121. ImmunogenX Celiac Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 122. ImmunogenX Celiac Drugs Product Portfolio Table 123. ImmunogenX Recent Development Table 124. F Hoffmann-La Roche Company Information Table 125. F Hoffmann-La Roche Business Overview Table 126. F Hoffmann-La Roche Celiac Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 127. F Hoffmann-La Roche Celiac Drugs Product Portfolio Table 128. F Hoffmann-La Roche Recent Development Table 129. Celimmune Company Information Table 130. Celimmune Business Overview Table 131. Celimmune Celiac Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 132. Celimmune Celiac Drugs Product Portfolio Table 133. Celimmune Recent Development Table 134. Celgene Company Information Table 135. Celgene Business Overview Table 136. Celgene Celiac Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 137. Celgene Celiac Drugs Product Portfolio Table 138. Celgene Recent Development Table 139. Bristol-Myers Squibb Company Information Table 140. Bristol-Myers Squibb Business Overview Table 141. Bristol-Myers Squibb Celiac Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 142. Bristol-Myers Squibb Celiac Drugs Product Portfolio Table 143. Bristol-Myers Squibb Recent Development Table 144. Biotest Company Information Table 145. Biotest Business Overview Table 146. Biotest Celiac Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 147. Biotest Celiac Drugs Product Portfolio Table 148. Biotest Recent Development Table 149. BioLineRx Company Information Table 150. BioLineRx Business Overview Table 151. BioLineRx Celiac Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 152. BioLineRx Celiac Drugs Product Portfolio Table 153. BioLineRx Recent Development Table 154. Anthera Pharmaceuticals Company Information Table 155. Anthera Pharmaceuticals Business Overview Table 156. Anthera Pharmaceuticals Celiac Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 157. Anthera Pharmaceuticals Celiac Drugs Product Portfolio Table 158. Anthera Pharmaceuticals Recent Development Table 159. ADMA Biologics Company Information Table 160. ADMA Biologics Business Overview Table 161. ADMA Biologics Celiac Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 162. ADMA Biologics Celiac Drugs Product Portfolio Table 163. ADMA Biologics Recent Development Table 164. Key Raw Materials Table 165. Raw Materials Key Suppliers Table 166. Celiac Drugs Distributors List Table 167. Celiac Drugs Customers List Table 168. Research Programs/Design for This Report Table 169. Authors List of This Report Table 170. Secondary Sources Table 171. Primary Sources List of Figures Figure 1. Celiac Drugs Product Image Figure 2. Global Celiac Drugs Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Celiac Drugs Sales Value (2021-2032) & (US$ Million) Figure 4. Global Celiac Drugs Sales (2021-2032) & (k units) Figure 5. Global Celiac Drugs Sales Average Price (US$/unit) & (2021-2032) Figure 6. Global Celiac Drugs Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. First Line Of Treatment Image Figure 10. Second Line Of Treatment Image Figure 11. Global Celiac Drugs Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 12. Global Celiac Drugs Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Celiac Drugs Sales Volume Share by Type (2021-2032) Figure 14. Global Celiac Drugs Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Celiac Drugs Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Celiac Drugs Sales Value Share by Type (2021-2032) Figure 17. Women Image Figure 18. Men Image Figure 19. Children Image Figure 20. Global Celiac Drugs Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 21. Global Celiac Drugs Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Celiac Drugs Sales Volume Share by Application (2021-2032) Figure 23. Global Celiac Drugs Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Celiac Drugs Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Celiac Drugs Sales Value Share by Application (2021-2032) Figure 26. Global Celiac Drugs Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 27. Global Celiac Drugs Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Celiac Drugs Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Celiac Drugs Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Celiac Drugs Sales Value (2021-2032) & (US$ Million) Figure 31. North America Celiac Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Celiac Drugs Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Celiac Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Celiac Drugs Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Celiac Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Celiac Drugs Sales Value (2021-2032) & (US$ Million) Figure 37. South America Celiac Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Celiac Drugs Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Celiac Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Celiac Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Celiac Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Celiac Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Celiac Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Celiac Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Celiac Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Celiac Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Celiac Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Celiac Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Celiac Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Celiac Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Celiac Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Celiac Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Celiac Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Celiac Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Celiac Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Celiac Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Celiac Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Celiac Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Celiac Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Celiac Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Celiac Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Celiac Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Celiac Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Celiac Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Celiac Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Celiac Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Celiac Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Celiac Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Celiac Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Celiac Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Celiac Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Celiac Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Celiac Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Celiac Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Celiac Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Celiac Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Celiac Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Celiac Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Celiac Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Celiac Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Celiac Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Celiac Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Celiac Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Celiac Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Celiac Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Celiac Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Celiac Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Celiac Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Celiac Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Celiac Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Celiac Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Celiac Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Celiac Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Celiac Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Celiac Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Celiac Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Celiac Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Celiac Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Celiac Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Celiac Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Celiac Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Celiac Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Celiac Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Celiac Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Celiac Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Celiac Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Celiac Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Celiac Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Celiac Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Celiac Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Celiac Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Celiac Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Celiac Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Celiac Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Celiac Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Celiac Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Celiac Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Celiac Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Celiac Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Celiac Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Celiac Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Celiac Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Celiac Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Celiac Drugs Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Celiac Drugs Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • First Line Of Treatment
  • Second Line Of Treatment
Applications
  • Women
  • Men
  • Children
Companies covered
  • Johnson & Johnson
  • Novartis
  • Merck
  • Biogen
  • Bayer
  • Amgen
  • LFB Group
  • Kedrion Biopharma
  • Innovate Biopharmaceuticals
  • ImmusanT
  • Immunomedics
  • ImmunogenX
  • F Hoffmann-La Roche
  • Celimmune
  • Celgene
  • Bristol-Myers Squibb
  • Biotest
  • BioLineRx
  • Anthera Pharmaceuticals
  • ADMA Biologics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Celiac Drugs Sales Value (2021-2032)
  4. 1.2.2 Global Celiac Drugs Sales Volume (2021-2032)
  5. 1.2.3 Global Celiac Drugs Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Celiac Drugs Market Dynamics
  1. 2.1 Celiac Drugs Industry Trends
  2. 2.2 Celiac Drugs Industry Drivers
  3. 2.3 Celiac Drugs Industry Opportunities and Challenges
  4. 2.4 Celiac Drugs Industry Restraints
3 Celiac Drugs Market by Company
  1. 3.1 Global Celiac Drugs Company Revenue Ranking in 2025
  2. 3.2 Global Celiac Drugs Revenue by Company (2021-2026)
  3. 3.3 Global Celiac Drugs Sales Volume by Company (2021-2026)
  4. 3.4 Global Celiac Drugs Average Price by Company (2021-2026)
  5. 3.5 Global Celiac Drugs Company Ranking (2024-2026)
  6. 3.6 Global Celiac Drugs Company Manufacturing Base and Headquarters
  7. 3.7 Global Celiac Drugs Company Product Type and Application
  8. 3.8 Global Celiac Drugs Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Celiac Drugs Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Celiac Drugs Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Celiac Drugs Market by Type
  1. 4.1 Celiac Drugs Type Introduction
  2. 4.1.1 First Line Of Treatment
  3. 4.1.2 Second Line Of Treatment
  4. 4.2 Global Celiac Drugs Sales Volume by Type
  5. 4.2.1 Global Celiac Drugs Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Celiac Drugs Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Celiac Drugs Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Celiac Drugs Sales Value by Type
  9. 4.3.1 Global Celiac Drugs Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Celiac Drugs Sales Value by Type (2021-2032)
  11. 4.3.3 Global Celiac Drugs Sales Value Share by Type (2021-2032)
5 Celiac Drugs Market by Application
  1. 5.1 Celiac Drugs Application Introduction
  2. 5.1.1 Women
  3. 5.1.2 Men
  4. 5.1.3 Children
  5. 5.2 Global Celiac Drugs Sales Volume by Application
  6. 5.2.1 Global Celiac Drugs Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Celiac Drugs Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Celiac Drugs Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Celiac Drugs Sales Value by Application
  10. 5.3.1 Global Celiac Drugs Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Celiac Drugs Sales Value by Application (2021-2032)
  12. 5.3.3 Global Celiac Drugs Sales Value Share by Application (2021-2032)
6 Celiac Drugs Regional Sales and Value Analysis
  1. 6.1 Global Celiac Drugs Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Celiac Drugs Sales by Region (2021-2032)
  3. 6.2.1 Global Celiac Drugs Sales by Region: 2021-2026
  4. 6.2.2 Global Celiac Drugs Sales by Region (2027-2032)
  5. 6.3 Global Celiac Drugs Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Celiac Drugs Sales Value by Region (2021-2032)
  7. 6.4.1 Global Celiac Drugs Sales Value by Region: 2021-2026
  8. 6.4.2 Global Celiac Drugs Sales Value by Region (2027-2032)
  9. 6.5 Global Celiac Drugs Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Celiac Drugs Sales Value (2021-2032)
  12. 6.6.2 North America Celiac Drugs Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Celiac Drugs Sales Value (2021-2032)
  15. 6.7.2 Europe Celiac Drugs Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Celiac Drugs Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Celiac Drugs Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Celiac Drugs Sales Value (2021-2032)
  21. 6.9.2 South America Celiac Drugs Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Celiac Drugs Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Celiac Drugs Sales Value Share by Country, 2025 VS 2032
7 Celiac Drugs Country-level Sales and Value Analysis
  1. 7.1 Global Celiac Drugs Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Celiac Drugs Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Celiac Drugs Sales by Country (2021-2032)
  4. 7.3.1 Global Celiac Drugs Sales by Country (2021-2026)
  5. 7.3.2 Global Celiac Drugs Sales by Country (2027-2032)
  6. 7.4 Global Celiac Drugs Sales Value by Country (2021-2032)
  7. 7.4.1 Global Celiac Drugs Sales Value by Country (2021-2026)
  8. 7.4.2 Global Celiac Drugs Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Celiac Drugs Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Celiac Drugs Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Celiac Drugs Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Celiac Drugs Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Celiac Drugs Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Celiac Drugs Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Celiac Drugs Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Celiac Drugs Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Celiac Drugs Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Celiac Drugs Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Celiac Drugs Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Celiac Drugs Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Celiac Drugs Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Celiac Drugs Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Celiac Drugs Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Celiac Drugs Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Celiac Drugs Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Celiac Drugs Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Celiac Drugs Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Celiac Drugs Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Celiac Drugs Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Celiac Drugs Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Celiac Drugs Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Celiac Drugs Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Celiac Drugs Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Celiac Drugs Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Celiac Drugs Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Celiac Drugs Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Celiac Drugs Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Celiac Drugs Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Celiac Drugs Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Celiac Drugs Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Celiac Drugs Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Celiac Drugs Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Celiac Drugs Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Celiac Drugs Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Celiac Drugs Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Celiac Drugs Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Celiac Drugs Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Celiac Drugs Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Celiac Drugs Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Celiac Drugs Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Celiac Drugs Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Celiac Drugs Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Celiac Drugs Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Celiac Drugs Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Celiac Drugs Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Celiac Drugs Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Celiac Drugs Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Celiac Drugs Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Celiac Drugs Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Celiac Drugs Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Celiac Drugs Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Celiac Drugs Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Celiac Drugs Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Celiac Drugs Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Celiac Drugs Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Celiac Drugs Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Celiac Drugs Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Celiac Drugs Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Celiac Drugs Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Celiac Drugs Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Celiac Drugs Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Celiac Drugs Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Celiac Drugs Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Celiac Drugs Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Celiac Drugs Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Celiac Drugs Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Celiac Drugs Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Celiac Drugs Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Celiac Drugs Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Celiac Drugs Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Celiac Drugs Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Celiac Drugs Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Celiac Drugs Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Celiac Drugs Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Celiac Drugs Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Celiac Drugs Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Celiac Drugs Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Celiac Drugs Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Celiac Drugs Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Celiac Drugs Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Celiac Drugs Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Celiac Drugs Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Johnson & Johnson
  2. 8.1.1 Johnson & Johnson Company Information
  3. 8.1.2 Johnson & Johnson Business Overview
  4. 8.1.3 Johnson & Johnson Celiac Drugs Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Johnson & Johnson Celiac Drugs Product Portfolio
  6. 8.1.5 Johnson & Johnson Recent Developments
  7. 8.2 Novartis
  8. 8.2.1 Novartis Company Information
  9. 8.2.2 Novartis Business Overview
  10. 8.2.3 Novartis Celiac Drugs Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Novartis Celiac Drugs Product Portfolio
  12. 8.2.5 Novartis Recent Developments
  13. 8.3 Merck
  14. 8.3.1 Merck Company Information
  15. 8.3.2 Merck Business Overview
  16. 8.3.3 Merck Celiac Drugs Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Merck Celiac Drugs Product Portfolio
  18. 8.3.5 Merck Recent Developments
  19. 8.4 Biogen
  20. 8.4.1 Biogen Company Information
  21. 8.4.2 Biogen Business Overview
  22. 8.4.3 Biogen Celiac Drugs Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Biogen Celiac Drugs Product Portfolio
  24. 8.4.5 Biogen Recent Developments
  25. 8.5 Bayer
  26. 8.5.1 Bayer Company Information
  27. 8.5.2 Bayer Business Overview
  28. 8.5.3 Bayer Celiac Drugs Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Bayer Celiac Drugs Product Portfolio
  30. 8.5.5 Bayer Recent Developments
  31. 8.6 Amgen
  32. 8.6.1 Amgen Company Information
  33. 8.6.2 Amgen Business Overview
  34. 8.6.3 Amgen Celiac Drugs Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Amgen Celiac Drugs Product Portfolio
  36. 8.6.5 Amgen Recent Developments
  37. 8.7 LFB Group
  38. 8.7.1 LFB Group Company Information
  39. 8.7.2 LFB Group Business Overview
  40. 8.7.3 LFB Group Celiac Drugs Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 LFB Group Celiac Drugs Product Portfolio
  42. 8.7.5 LFB Group Recent Developments
  43. 8.8 Kedrion Biopharma
  44. 8.8.1 Kedrion Biopharma Company Information
  45. 8.8.2 Kedrion Biopharma Business Overview
  46. 8.8.3 Kedrion Biopharma Celiac Drugs Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Kedrion Biopharma Celiac Drugs Product Portfolio
  48. 8.8.5 Kedrion Biopharma Recent Developments
  49. 8.9 Innovate Biopharmaceuticals
  50. 8.9.1 Innovate Biopharmaceuticals Company Information
  51. 8.9.2 Innovate Biopharmaceuticals Business Overview
  52. 8.9.3 Innovate Biopharmaceuticals Celiac Drugs Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Innovate Biopharmaceuticals Celiac Drugs Product Portfolio
  54. 8.9.5 Innovate Biopharmaceuticals Recent Developments
  55. 8.10 ImmusanT
  56. 8.10.1 ImmusanT Company Information
  57. 8.10.2 ImmusanT Business Overview
  58. 8.10.3 ImmusanT Celiac Drugs Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 ImmusanT Celiac Drugs Product Portfolio
  60. 8.10.5 ImmusanT Recent Developments
  61. 8.11 Immunomedics
  62. 8.11.1 Immunomedics Company Information
  63. 8.11.2 Immunomedics Business Overview
  64. 8.11.3 Immunomedics Celiac Drugs Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Immunomedics Celiac Drugs Product Portfolio
  66. 8.11.5 Immunomedics Recent Developments
  67. 8.12 ImmunogenX
  68. 8.12.1 ImmunogenX Company Information
  69. 8.12.2 ImmunogenX Business Overview
  70. 8.12.3 ImmunogenX Celiac Drugs Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 ImmunogenX Celiac Drugs Product Portfolio
  72. 8.12.5 ImmunogenX Recent Developments
  73. 8.13 F Hoffmann-La Roche
  74. 8.13.1 F Hoffmann-La Roche Company Information
  75. 8.13.2 F Hoffmann-La Roche Business Overview
  76. 8.13.3 F Hoffmann-La Roche Celiac Drugs Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 F Hoffmann-La Roche Celiac Drugs Product Portfolio
  78. 8.13.5 F Hoffmann-La Roche Recent Developments
  79. 8.14 Celimmune
  80. 8.14.1 Celimmune Company Information
  81. 8.14.2 Celimmune Business Overview
  82. 8.14.3 Celimmune Celiac Drugs Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Celimmune Celiac Drugs Product Portfolio
  84. 8.14.5 Celimmune Recent Developments
  85. 8.15 Celgene
  86. 8.15.1 Celgene Company Information
  87. 8.15.2 Celgene Business Overview
  88. 8.15.3 Celgene Celiac Drugs Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Celgene Celiac Drugs Product Portfolio
  90. 8.15.5 Celgene Recent Developments
  91. 8.16 Bristol-Myers Squibb
  92. 8.16.1 Bristol-Myers Squibb Company Information
  93. 8.16.2 Bristol-Myers Squibb Business Overview
  94. 8.16.3 Bristol-Myers Squibb Celiac Drugs Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 Bristol-Myers Squibb Celiac Drugs Product Portfolio
  96. 8.16.5 Bristol-Myers Squibb Recent Developments
  97. 8.17 Biotest
  98. 8.17.1 Biotest Company Information
  99. 8.17.2 Biotest Business Overview
  100. 8.17.3 Biotest Celiac Drugs Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 Biotest Celiac Drugs Product Portfolio
  102. 8.17.5 Biotest Recent Developments
  103. 8.18 BioLineRx
  104. 8.18.1 BioLineRx Company Information
  105. 8.18.2 BioLineRx Business Overview
  106. 8.18.3 BioLineRx Celiac Drugs Sales, Value and Gross Margin (2021-2026)
  107. 8.18.4 BioLineRx Celiac Drugs Product Portfolio
  108. 8.18.5 BioLineRx Recent Developments
  109. 8.19 Anthera Pharmaceuticals
  110. 8.19.1 Anthera Pharmaceuticals Company Information
  111. 8.19.2 Anthera Pharmaceuticals Business Overview
  112. 8.19.3 Anthera Pharmaceuticals Celiac Drugs Sales, Value and Gross Margin (2021-2026)
  113. 8.19.4 Anthera Pharmaceuticals Celiac Drugs Product Portfolio
  114. 8.19.5 Anthera Pharmaceuticals Recent Developments
  115. 8.20 ADMA Biologics
  116. 8.20.1 ADMA Biologics Company Information
  117. 8.20.2 ADMA Biologics Business Overview
  118. 8.20.3 ADMA Biologics Celiac Drugs Sales, Value and Gross Margin (2021-2026)
  119. 8.20.4 ADMA Biologics Celiac Drugs Product Portfolio
  120. 8.20.5 ADMA Biologics Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Celiac Drugs Value Chain Analysis
  2. 9.1.1 Celiac Drugs Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Celiac Drugs Sales Mode & Process
  6. 9.2 Celiac Drugs Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Celiac Drugs Distributors
  9. 9.2.3 Celiac Drugs Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst